Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis

2021 ◽  
pp. 1-7
Author(s):  
T Komai ◽  
Y Iwasaki ◽  
Y Tsuchida ◽  
N Hanata ◽  
H Tsuchiya ◽  
...  
Keyword(s):  
Plasma Exchange ◽  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Efficacy And Safety ◽  
Amyopathic Dermatomyositis ◽  
Clinically Amyopathic Dermatomyositis

scholarly journals Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis

2020 ◽  
Vol &NA; (6) ◽  
pp. 644-649 ◽  
Author(s):  
Yu-Zhou Gan ◽  
Li-Hua Zhang ◽  
Lin Ma ◽  
Feng Sun ◽  
Yu-Hui Li ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Amyopathic Dermatomyositis ◽  
Clinically Amyopathic Dermatomyositis

Efficacy and safety of transbronchial cryobiopsy in interstitial lung diseases

2017 ◽  
Author(s):  
Ahmed Ehab ◽  
Mohammad Khairy El-Badrawy ◽  
Amr Abdelhamed Moawad ◽  
Mohammad Eldesoky Abo-Shehata
Keyword(s):  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Efficacy And Safety

scholarly journals Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange

2018 ◽  
Vol 57 (13) ◽  
pp. 1935-1938 ◽  
Author(s):  
Mizuki Yagishita ◽  
Yuya Kondo ◽  
Toshihiko Terasaki ◽  
Mayu Terasaki ◽  
Masaru Shimizu ◽  
...  
Keyword(s):  
Plasma Exchange ◽  
Interstitial Pneumonia ◽  
Amyopathic Dermatomyositis ◽  
Clinically Amyopathic Dermatomyositis

scholarly journals Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety

2021 ◽  
Vol 2 ◽  
Author(s):  
Renata G. Mendes ◽  
Viviane Castello-Simões ◽  
Renata Trimer ◽  
Adriana S. Garcia-Araújo ◽  
Andrea Lucia Gonçalves Da Silva ◽  
...  
Keyword(s):  
Exercise Training ◽  
Pulmonary Rehabilitation ◽  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Exercise Intolerance ◽  
Muscle Dysfunction ◽  
Efficacy And Safety ◽  
Skeletal Muscle Dysfunction ◽  
Frequency Components

Interstitial lung diseases (ILDs) comprise a heterogeneous group of disorders (such as idiopathic pulmonary fibrosis, sarcoidosis, asbestosis, and pneumonitis) characterized by lung parenchymal impairment, inflammation, and fibrosis. The shortness of breath (i.e., dyspnea) is a hallmark and disabling symptom of ILDs. Patients with ILDs may also exhibit skeletal muscle dysfunction, oxygen desaturation, abnormal respiratory patterns, pulmonary hypertension, and decreased cardiac function, contributing to exercise intolerance and limitation of day-to-day activities. Pulmonary rehabilitation (PR) including physical exercise is an evidence-based approach to benefit functional capacity, dyspnea, and quality of life in ILD patients. However, despite recent advances and similarities with other lung diseases, the field of PR for patients with ILD requires further evidence. This mini-review aims to explore the exercise-based PR delivered around the world and evidence supporting prescription modes, considering type, intensity, and frequency components, as well as efficacy and safety of exercise training in ILDs. This review will be able to strengthen the rationale for exercise training recommendations as a core component of the PR for ILD patients.

scholarly journals EFFICACY AND SAFETY OF NINTEDANIB IN US/CANADIAN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES: FURTHER ANALYSES OF THE INBUILD TRIAL

CHEST Journal ◽  
2020 ◽  
Vol 158 (4) ◽  
pp. A2613-A2615
Author(s):  
Shane Shapera ◽  
Teng Moua ◽  
Anoop Nambiar ◽  
Lake Morrison ◽  
Martin Kolb ◽  
...  
Keyword(s):  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Efficacy And Safety

scholarly journals Interstitial lung diseases associated with amyopathic dermatomyositis

2006 ◽  
Vol 28 (5) ◽  
pp. 1005-1012 ◽  
Author(s):  
T. Suda ◽  
T. Fujisawa ◽  
N. Enomoto ◽  
Y. Nakamura ◽  
N. Inui ◽  
...  
Keyword(s):  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Amyopathic Dermatomyositis

scholarly journals Feasibility, utility, and safety of transbronchial cryobiopsy for interstitial lung diseases in Japan

2021 ◽  
Vol 16 ◽  
Author(s):  
Takato Ikeda ◽  
Akira Nakao ◽  
Fumiyasu Igata ◽  
Yoshiaki Kinoshita ◽  
Hisako Kushima ◽  
...  
Keyword(s):  
Lung Disease ◽  
Lung Diseases ◽  
Interstitial Lung Diseases ◽  
Efficacy And Safety ◽  
Diffuse Lung Disease ◽  
Biopsy Site ◽  
Transbronchial Lung Cryobiopsy ◽  
A New Technique ◽  
Diffuse Lung ◽  
Average Sample

Background: Transbronchial lung cryobiopsy (TBLC) is a new technique that enables larger tissue collection than can be obtained by conventional transbronchial lung biopsy. TBLC is becoming popular worldwide and is performed for diffuse lung disease and lung cancer. However, only a few reports of TBLC have been published in Japan. This study was performed to evaluate the efficacy and safety of TBLC at our hospital and compare these findings with past reports.Methods: From April 2018 to January 2020, 38 patients who underwent TBLC for diffuse lung disease at our hospital were evaluated with respect to age, sex, biopsy site, biopsy size, diagnostic disease, and complications.Results: The patients who underwent TBLC constituted 20 men and 18 women with an average age of 63.7 years. The average sample size was 5.7 mm, and the diagnostic rate was 65.7% (25/38). Grade ≥2 complications included bleeding (15.8%), pneumothorax (2.6%), and atrial fibrillation (2.6%).Conclusions: TBLC was considered to be useful for the diagnosis of diffuse lung disease and could be safely performed.

Sign in / Sign up

Export Citation Format

Share Document